Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1174.37x is 238% below its 5-year average of -347.48x, near the high end of its 5-year range (-5135.76x–-27.76x).
88.56% below its 12-month average of -622.80x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2026 (2026-06-30): -1275.49x.
INTEREST COVERAGE RATIO
-1174.37x
INTEREST COVERAGE RATIO AVG TTM
-622.80x
INTEREST COVERAGE RATIO AVG 3Y
-112.65x
INTEREST COVERAGE RATIO AVG 5Y
-347.48x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-88.56%
CURRENT VS 3Y AVG
-942.49%
CURRENT VS 5Y AVG
-237.96%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 430 covered companies
CURRENT VS SECTOR MEDIAN
-21098.01%
vs the sector median at left
Intelligent Bio Solutions Inc.
Market Cap
$5.27M
Interest Coverage Ratio
-1174.37x
TTM Avg
-622.80x
3Y Avg
-112.65x
5Y Avg
-347.48x
Market Cap
$5.16M
Interest Coverage Ratio
-13.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.29M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
Market Cap
$5.19M
Interest Coverage Ratio
-25.56x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.32M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.01M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
Market Cap
$4.94M
Interest Coverage Ratio
-16.26x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.27M | -1174.37x | -622.80x | -112.65x | -347.48x |
| Pulmatrix, Inc. (PULM)vs › | $5.22M | N/A | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.16M | -13.75x | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.29M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | -25.56x | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -2.90x | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.04M | N/A | 1.00x | 1.02x | 1.02x |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | -10.70x | 10.43x | 9.52x | 9.52x |
| CalciMedica, Inc. (CALC)vs › | $4.94M | -16.26x | N/A | N/A | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.51M | N/A | N/A | N/A | N/A |
Interest Coverage
-1174.4x
Debt/Equity
0.33
Current Ratio
1.44
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1275.49x |
| 2026-03-31 | -732.75x |
| 2025-12-31 | -46.41x |
| 2025-09-30 | -750.98x |
| 2025-06-30 | -308.38x |
| 2025-03-31 | -181.77x |
| 2024-12-31 | -167.71x |
| 2024-09-30 | -127.71x |
| 2024-06-30 | -51.54x |
| 2024-03-31 | -69.22x |
| 2023-12-31 | -61.33x |
| 2023-09-30 | -67.46x |
| 2023-06-30 | -44.97x |
| 2023-03-31 | -75.98x |
| 2022-12-31 | -27.76x |
| 2022-09-30 | -1144.01x |
| 2022-06-30 | -788.85x |
| 2022-03-31 | -318.43x |
| 2021-12-31 | -5135.76x |
| 2021-06-30 | -361.44x |
| 2021-03-31 | -169.20x |
| 2020-12-31 | -0.93x |
| 2020-09-30 | -7.72x |
| 2020-06-30 | -6.63x |
| 2020-03-31 | -0.35x |
| 2019-12-31 | -11.43x |
| 2019-09-30 | -4.12x |
| 2019-06-30 | -17.91x |
| 2019-03-31 | -8.66x |
| 2018-12-31 | -3.60x |
| 2018-09-30 | -8.97x |
| 2018-06-30 | -18.55x |
| 2018-03-31 | -7.66x |
| 2017-12-31 | -10.21x |
| 2017-09-30 | -7.96x |
| 2017-06-30 | -1.64x |
